ATF6 and colorectal carcinoma: In line with our results, external testing results identified 39% (classification task) and 35.9% (regression task) of individuals with CRC in cohort 1 as ATF6-high (Fig. 1b–e and Extended Data Fig. 1h,i), confirming the robustness and applicability of our AI methodology.